|
Glioblastoma
|
|
|
|
Das
A, Banik NL, Ray SK.
Retinoids induced astrocytic differentiation with down regulation of
telomerase activity and enhanced sensitivity to taxol for apoptosis in human
glioblastoma T98G and U87MG cells.
J Neurooncol.
2007 Nov 7; [Epub ahead of print]
Abstract
|
|
Melino G, Stephanou A,
Annicchiarico-Petruzzelli M, Finazzi-Agro A, Knight RA, Lightman SL
IGF-II
mRNA expression in LI human glioblastoma cell line parallels cell growth
Neurosci Lett. 1992 Sep 14;144(1-2):25-8 (Cell Culture Study, Abstract)
|
|
Siew-Ju See, Victor A. Levin, W.-K.
Alfred Yung, Kenneth R. Hess, Morris D. Groves
13-cis-Retinoic acid in the treatment of
recurrent glioblastoma multiforme
Neuro-Oncology, Vol. 6, No. 3, July
2004, 253 -- 258. (Retrospective Study, Abstract+)
|
|
|
|
Gliomas
|
|
|
Caecilia Wismeth, Peter Hau, Klaus Fabel,
Ulrike
Baumgart, Birgit Hirschmann, Horst Koch, Tanja Jauch, Oliver
Grauer, Lisa Drechsel, Alexander Brawanski, Ulrich Bogdahn, Andreas
Steinbrecher
Maintenance Therapy with 13-cis Retinoid Acid in High-Grade Glioma
at Complete Response After First-Line Multimodal Therapy – A Phase-II
Study
Journal of Neuro-Oncology, 68 (1): 79-86, May 2004. (Clinical Study,
Abstract+)
|
|
Klaus
Fabel, Peter Hau, Oliver Grauer, Tanya Jauch, Martin Proescholdt, Anton
Zellner, Andreas Steinbrecher, Alexander Brawanski, Ulrich Bogdahn
Neoadjuvant therapy with temozolomide and
13-cis-retinoic acid in high grade glioma - a phase II-study
38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract
No.
2090
(Clinical Study)
|
|
Jaeckle
KA, Hess KR, Yung WK, Greenberg H, Fine H, Schiff D, Pollack IF, Kuhn
J, Fink K, Mehta M, Cloughesy T, Nicholas MK, Chang S, Prados M; North
American Brain Tumor Consortium
Phase
II evaluation of temozolomide and 13-cis-retinoic acid for the treatment
of recurrent and progressive malignant glioma: a North American Brain
Tumor Consortium study
J Clin Oncol. 2003 Jun 15;21(12):2305-11
(Clinical
Study, Abstract)
|
|
V.
K. Puduvalli, W. K. A. Yung, M. Prados, J. Kuhn, K. Hess, M. Groves,
V. Levin, S. Chang, J. Zwiebel, T. Cloughesy
Phase II trial of fenretinide in patients
with recurrent malignant gliomas - A North American Brain Tumor Consortium
study
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
419
(Clinical Study)
|
|
Yung WK,
Kyritsis AP, Gleason MJ, Levin VA
Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid
Clin Cancer Res 1996 Dec;2(12):1931-5 (Clinical Study,
Abstract)
|
|
|
|
Medulloblastoma
|
|
|
Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, Lengauer C,
Cummins JM, Velculescu VE, Fults DW, McLendon RE, Bigner DD, Yan H
Identification of OTX2 as a Medulloblastoma Oncogene
Whose Product can be Targeted by All-Trans Retinoic Acid
Cancer
Res. 2005 Feb 1;65(3):919-24. (Laboratory Investigation,
Abstract+)
|
|
|
|
Meningioma
|
|
|
Puduvalli VK, Li JT, Chen L, McCutcheon
IE
Induction of apoptosis in primary meningioma cultures by
fenretinide
Cancer
Res. 2005 Feb 15;65(4):1547-53. (Laboratory Investigation,
Abstract)
|
|
|
|
Non-Nervous System
Tumors
|
|
|
|
Zheng
X, Chang RL, Cui XX, Kelly KA, Shih WJ, Lin Y, Strair R, Suh J, Han ZT,
Rabson A, Conney AH
Synergistic
effects of clinically achievable concentrations of
12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic
acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in
HL-60 cells
Oncol Res 2000;12(9-10):419-27 (Cell Culture Study,
Abstract)
|
|
Pili
R, Kruszewski MP, Hager BW, Lantz J, Carducci MA
Combination
of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and
angiogenesis
Cancer
Res 2001 Feb 15;61(4):1477-85 (Cell Culture Study,
Abstract & Full Text)
|
|
